Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions

Launched by INSTITUTO ECUATORIANO DE ENFERMEDADES DIGESTIVAS · Jul 23, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new method called detective flow imaging endoscopic ultrasonography (DFI-EUS) to help doctors better diagnose certain growths in the digestive system known as subepithelial lesions (SELs). These lesions can be benign, like leiomyomas, or malignant, like gastrointestinal stromal tumors (GISTs). The goal is to see if DFI-EUS can effectively identify these lesions without using contrast agents, which can sometimes cause side effects in patients. By comparing DFI-EUS with another technique called contrast-enhanced endoscopic ultrasound (CE-EUS), researchers hope to find a safer and more accurate way to diagnose these conditions.

To participate in the trial, patients need to be between the ages of 18 and 80 and should have been referred for an ultrasound to evaluate SELs. They must also be able to provide written consent to take part in the study. Those who have certain health issues that prevent the use of contrast agents or are pregnant cannot join. Participants will undergo the DFI-EUS or CE-EUS procedures, and they can expect to receive thorough monitoring and care throughout the trial. This research is important as it may lead to better diagnosis and treatment options for patients with these types of lesions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients referred to our center with an indication of EUS for the evaluation of SELs
• • Patients who authorized for DFI or CE-EUS.
• • Written informed consent
• Exclusion Criteria:
• • Patients with contraindication for contrast agent administration.
• • Any clinical condition which makes EUS-DFI or CE-EUS inviable
• • Pregnancy